Powerful Medical
9. April 2024

Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class

In a world where medical technology advances at an unprecedented pace, it’s the visionaries and innovators who lead the way in transforming healthcare. This year, we are honored to share that our co-founders, Martin Herman and Robert Herman, MD, have been recognized as part of the prestigious Forbes 30 Under 30 Europe 2024 list for their exceptional work in reshaping cardiovascular care.

Selected from thousands of nominations, Martin and Robert’s inclusion in this list is a reflection of their dedication to revolutionizing cardiac diagnostics through artificial intelligence. At Powerful Medical, we are committed to the early detection and timely management of acute heart attacks and 38 other heart conditions, a mission that has the potential to improve and save countless lives of cardiac patients.

Combining cutting-edge AI with deep medical expertise, we aim to provide healthcare professionals with innovative diagnostic tools. Our AI-powered certified ECG interpretation platform, PMcardio, enables quicker and more accurate detection of heart attacks, facilitating timely intervention that can significantly improve patient outcomes.

Joining a global community of young entrepreneurs and change-makers, Martin and Robert are now part of a network of individuals dedicated to making a lasting impact.

To compile the Forbes Europe 30 Under 30 ninth annual list, Forbes’ team delved into thousands of submissions online and sought recommendations from industry insiders and previous listees. The Forbes team, alongside an independent panel of judges, including notable figures like Renzo Rosso, Simona Tabasco, and Mo Farah, evaluated candidates based on factors such as funding, revenue, social impact, scale, creativity, and future potential.

“We could not have reached this milestone without the hard work and dedication of our entire team. Every day, their expertise and passion help bring our vision closer to reality. Our journey is also supported by our investors and partners, whose faith in our mission has been invaluable,” said Martin Herman, CEO of Powerful Medical. “Celebrating this achievement, we also extend our congratulations to everyone recognized in this year’s Forbes 30 Under 30 list. These individuals serve as an inspiration to us and, undoubtedly, to the generations that will follow.”

“As we continue our journey to enter new markets, integrate PMcardio into more healthcare institutions, accumulate more clinical evidence, and develop new AI models for conditions like heart failure, the recognition by Forbes inspires us to further innovate cardiovascular care, aiming to make a meaningful impact on patient lives worldwide.”, adds Dr. Robert Herman, Chief Medical Officer at Powerful Medical.

Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class
Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class

Stay on the pulse with our newsletter

Your submission was successful

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Advanced STEMI Detection and Improved Cath Lab Activation through ECG Transmission and Notifications

By utilizing advanced AI technology, PMcardio simplifies complex diagnostics, delivering real-time insights to support clinical decisions. Its Notification Functionality enhances communication and accelerates care delivery with manual and automated alerts, ensuring timely interventions.

Announcing the AI-ECG TIMI Study: A Multi-Center Validation

We are thrilled to announce the launch of the AI-ECG TIMI Study, a novel, international, multi-center observational study aimed at validating the use of AI to improve the detection and management of acute coronary syndromes (ACS).

Join 25,000 healthcare professionals who are already taking advantage of AI